[MYGN] QoQ Quarter Result on 30-Sep-2012 [#Q3]

Stock
[MYGN] Myriad Genetics, Inc.
Announcement Date
09-Nov-2012
Financial Year
2012
Quarter
30-Sep-2012 [#Q3]
Profit Trend
QoQ- 3.41%
YoY- 20.07%
Quarter Report
MYGN's Result
MYGN's Financial Summary
View:
Show?
Quarter Result
30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 CAGR
Revenue 174,116 156,472 149,140 133,437 132,965 129,777 122,811 26.22%
PBT 67,228 59,241 56,985 49,822 48,471 47,481 46,783 27.37%
Tax 23,153 21,349 21,949 19,686 19,330 17,866 18,487 16.20%
NP 44,075 37,892 35,036 30,136 29,141 29,615 28,296 34.40%
Tax Rate -34.44% -36.04% -38.52% -39.51% -39.88% -37.63% -39.52% -
Total Cost 130,041 118,580 114,104 103,301 103,824 100,162 94,515 23.72%
Ratio Analysis
30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 CAGR
NP Margin 25.31 24.22 23.49 22.58 21.92 22.82 23.04 6.47%
Per Share
30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 CAGR
EPS 0.55 0.47 0.43 0.37 0.35 0.35 0.33 40.61%
EPS Diluted 0.53 0.46 0.42 0.36 0.34 0.34 0.33 37.18%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.